Two-stage resection for bilobar colorectal liver metastases: R0 resection is the key

Annals of Surgical Oncology

Volumn 18, Issue 7, 2011, Pages 1939-1946

  Tsim, Nicole ^a   Healey, Andrew J ^a   Frampton, Adam E ^a   Habib, Nagy A ^a   Bansi, Devinder S ^b   Wasan, Harpreet ^a   Cleator, Susan J ^a   Stebbing, Justin ^a   Lowdell, Charles P ^a   Jackson, James E ^b   Tait, Paul ^b   Jiao, Long R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CETUXIMAB; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; BILE LEAKAGE; BILOBAR COLORECTAL LIVER METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CHEST INFECTION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER ABSCESS; LIVER HEMATOMA; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; REOPERATION; TREATMENT OUTCOME; TWO STAGE LIVER RESECTION; URINE RETENTION; WOUND INFECTION;

AGED; CATHETER ABLATION; COHORT STUDIES; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PORTAL VEIN; PROSPECTIVE STUDIES; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80051553000     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1533-y     Document Type: Article

References (36)

1. Jaeck D, Bachellier P, Guiguet M, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg. 1997;84:977-80. (Pubitemid 27310867)
2. Harmon KE, Ryan JA Jr, Biehl TR, et al. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg. 1999;177: 402-4. (Pubitemid 29252811)
3. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938-46. (Pubitemid 27106275)
4. Fortner JG, Silva JS, Golbey RB, et al. Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg. 1984;199:306-16. (Pubitemid 14194076)
5. Bismuth H, Adam R, Levi F, et al. Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg. 1996;224:509-20.
6. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg. 2000;231:480-6. (Pubitemid 30185853)
7. Kawasaki S, Makuuchi M, Kakazu T, et al. Resection for multiple metastatic liver tumors after portal embolization. Surgery. 1994;115:674-7. (Pubitemid 24189760)
8. de Baere T, Roche A, Elias D, et al. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology. 1996;24:1386-91. (Pubitemid 26399035)
9. Elias D, Ouellet JF, de Baere T, et al. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery. 2002;131: 294-9. (Pubitemid 34229782)
10. Elias D, de Baere T, Roche A, et al. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg. 1999;86:784-8. (Pubitemid 29271944)
11. Jaeck D, Oussoultzoglou E, Rosso E, et al. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004;240:1037-49.
12. Adam R, Laurent A, Azoulay D, et al. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777-85.
13. Shimada H, Tanaka K, Masui H, et al. Results of surgical treatment for multiple (>or = 5 nodules) bi-lobar hepatic metastases from colorectal cancer. Langenbecks Arch Surg. 2004;389: 114-21. (Pubitemid 38660681)
14. Jaeck D, Bachellier P, Nakano H, et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg. 2003;185: 221-9. (Pubitemid 36298887)
15. Bachellier P, Ayav A, Pai M, Weber JC, Rosso E, Jaeck D, Habib NA, Jiao LR. Laparoscopic liver resection assisted with radiofrequency. Am J Surg. 2007;193:427-30. (Pubitemid 46412251)
16. Jiao LR, Ayav A, Navarra G, Sommerville C, Pai M, Damrah O, Khorsandi S, Habib NA. Laparoscopic liver resection assisted by the laparoscopic Habib Sealer. Surgery. 2008;144:770-4.
17. Covey AM, Tuorto S, Brody LA, et al. Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. AJR Am J Roentgenol. 2005; 185:1620-6.
18. Ayav A, Bachellier P, Habib NA, et al. Impact of radiofrequency assisted hepatectomy for reduction of transfusion requirements. Am J Surg. 2007;193:143-8. (Pubitemid 46111027)
19. Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247:49-57.
20. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg. 2004;240:644-57.
21. Fan ST, Ng IO, Poon RT, et al. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg. 1999;134:1124-30. (Pubitemid 29473204)
22. Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg. 2007;205:27-36. (Pubitemid 47016970)
23. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-18.
24. DeMatteo RP, Palese C, Jarnagin WR, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg. 2000;4:178-84.
25. Tung-Ping PR, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232:10-24. (Pubitemid 30456545)
26. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-6.
27. Adam R, Pascal G, Azoulay D, et al. Liver resection for colorectal metastases: the third hepatectomy. Ann Surg. 2003;238: 871-83.
28. Arru M, Aldrighetti L, Castoldi R, et al. Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2008;32:93-103. (Pubitemid 50004245)
29. Pawlik TM, Scoggins CR, Zorzi D, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg. 2005;241:715-22.
30. Kokudo N, Miki Y, Sugai S, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg. 2002;137:833-40. (Pubitemid 34743176)
31. Cady B, Jenkins RL, Steele GD Jr, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg. 1998;227:566-71. (Pubitemid 28363275)
32. Chua SC, Groves AM, Kayani I, et al. The impact of 18F-FDG PET/CT in patients with liver metastases. Eur J Nucl Med Mol Imaging. 2007;34:1906-14. (Pubitemid 350212127)
33. Huguet EL, Old S, Praseedom RK, et al. F18-FDG-PET evaluation of patients for resection of colorectal liver metastases. Hepatogastroenterology. 2007;54:1667-71. (Pubitemid 350068450)
34. Covey AM, Brown KT, Jarnagin WR, et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg. 2008;247:451-5.
35. Aoki T, Umekita N, Tanaka S, et al. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery. 2008;143:706-14.
36. Petrowsky H, Gonen M, Jarnagin W, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg. 2002;235:863-71. (Pubitemid 34547306)